Analysts expect ENvue Medical, Inc. to report revenue of 237,324.15 for 2017, against a range of 224,514.58 to 250,133.72. The most recent reported year, 2018, came in at 318,000.00, a 11.3% miss against the 358,437.36 consensus.
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Reported (Actual) | - | 318,000.00 | - | ||
| High Estimate | 250,133.72 | 388,176.55 | 652,656.71 | ||
| Low Estimate | 224,514.58 | 328,698.17 | 566,977.41 | ||
| Consensus Estimate | 237,324.15 | 358,437.36 | 609,817.06 |
Analysts expect ENvue Medical, Inc. to report earnings per share of -1,970.51 for 2017, against a range of -2,120.76 to -1,820.26. The most recent reported year, 2018, came in at -1,410.00, a 0.9% beat against the -1,422.64 consensus.
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Reported (Actual) | - | -1,410.00 | - | ||
| High Estimate | -1,820.26 | -1,317.55 | -1,987.69 | ||
| Low Estimate | -2,120.76 | -1,527.73 | -2,276.45 | ||
| Consensus Estimate | -1,970.51 | -1,422.64 | -2,132.07 |